| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 10 1245-1250, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
D Bryan, CJ Sexton, D Williams, IM Leigh and IA McKay
Department of Experimental Dermatology, London Hospital Medical College, United Kingdom.
Interleukin 6 (IL-6) is a pleiotropic cytokine produced by cells in response to injurious stimuli including viral infections and UV light. Numerous human keratinocyte-derived lines overexpress IL-6 and have been shown to respond to IL-6 as a mitogen. In a survey of such lines, we discovered that two lines, SiHa and Caski, which harbor human papillomavirus (HPV) type 16 genomes, showed the highest levels of secretion. We have, therefore, asked whether immortalization of human keratinocytes with HPV 16 could result in elevated secretion of IL-6. Oral keratinocytes were transfected with a plasmid expressing the entire HPV type 16 early region under the control of the Moloney leukemia virus long terminal repeat promoter. Three immortal lines were derived and tested for their ability to secrete biologically active IL-6. These lines showed 2-, 3-, and 9-fold increases in detectable IL-6 when compared with parental strains of keratinocytes. Cells from one of these lines, T103C, showed a negative growth response to IL-6-neutralizing antisera, suggesting that the secreted IL-6 acted as an autocrine growth stimulator.
This article has been cited by other articles:
![]() |
A Wozniacka, A Carter, and D P Mccauliffe Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit Lupus, February 1, 2002; 11(2): 71 - 81. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |